218 related articles for article (PubMed ID: 15110849)
21. Effects of a combretastatin A4 analogous chalcone and its Pt-complex on cancer cells: A comparative study of uptake, cell cycle and damage to cellular compartments.
Zoldakova M; Kornyei Z; Brown A; Biersack B; Madarász E; Schobert R
Biochem Pharmacol; 2010 Nov; 80(10):1487-96. PubMed ID: 20709029
[TBL] [Abstract][Full Text] [Related]
22. Antimitotic and antiproliferative activities of chalcones: forward structure-activity relationship.
Boumendjel A; Boccard J; Carrupt PA; Nicolle E; Blanc M; Geze A; Choisnard L; Wouessidjewe D; Matera EL; Dumontet C
J Med Chem; 2008 Apr; 51(7):2307-10. PubMed ID: 18293907
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of novel pyrazolic analogues of chalcones and their 3-aryl-4-(3-aryl-4,5-dihydro-1H-pyrazol-5-yl)-1-phenyl-1H-pyrazole derivatives as potential antitumor agents.
Insuasty B; Tigreros A; Orozco F; Quiroga J; Abonía R; Nogueras M; Sanchez A; Cobo J
Bioorg Med Chem; 2010 Jul; 18(14):4965-74. PubMed ID: 20594863
[TBL] [Abstract][Full Text] [Related]
24. DNA-targeting pyrroloquinoline-linked butenone and chalcones: synthesis and biological evaluation.
Dalla Via L; Gia O; Chiarelotto G; Ferlin MG
Eur J Med Chem; 2009 Jul; 44(7):2854-61. PubMed ID: 19155103
[TBL] [Abstract][Full Text] [Related]
25. Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure-activity relationships.
Cabrera M; Simoens M; Falchi G; Lavaggi ML; Piro OE; Castellano EE; Vidal A; Azqueta A; Monge A; de Ceráin AL; Sagrera G; Seoane G; Cerecetto H; González M
Bioorg Med Chem; 2007 May; 15(10):3356-67. PubMed ID: 17383189
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and antitumor activity of novel nitrogen mustard-linked chalcones.
Fang X; Yang B; Cheng Z; Yang M; Su N; Zhou L; Zhou J
Arch Pharm (Weinheim); 2013 Apr; 346(4):292-9. PubMed ID: 23519571
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of a novel series of chalcones incorporated pyrazole moiety as anticancer and antimicrobial agents.
Mohamed MF; Mohamed MS; Shouman SA; Fathi MM; Abdelhamid IA
Appl Biochem Biotechnol; 2012 Nov; 168(5):1153-62. PubMed ID: 22948604
[TBL] [Abstract][Full Text] [Related]
28. Solution-phase parallel synthesis of substituted chalcones and their antiparasitary activity against Giardia lamblia.
Montes-Avila J; Díaz-Camacho SP; Sicairos-Félix J; Delgado-Vargas F; Rivero IA
Bioorg Med Chem; 2009 Sep; 17(18):6780-5. PubMed ID: 19683930
[TBL] [Abstract][Full Text] [Related]
29. Synthetic chalcones as potential anti-inflammatory and cancer chemopreventive agents.
Won SJ; Liu CT; Tsao LT; Weng JR; Ko HH; Wang JP; Lin CN
Eur J Med Chem; 2005 Jan; 40(1):103-12. PubMed ID: 15642415
[TBL] [Abstract][Full Text] [Related]
30. Quinolinyl and quinolinyl N-oxide chalcones: synthesis, antifungal and cytotoxic activities.
de Carvalho Tavares L; Johann S; Maria de Almeida Alves T; Guerra JC; Maria de Souza-Fagundes E; Cisalpino PS; Bortoluzzi AJ; Caramori GF; de Mattos Piccoli R; Braibante HT; Braibante ME; Pizzolatti MG
Eur J Med Chem; 2011 Sep; 46(9):4448-56. PubMed ID: 21816519
[TBL] [Abstract][Full Text] [Related]
31. Activity of novel quinoxaline-derived chalcones on in vitro glioma cell proliferation.
Mielcke TR; Mascarello A; Filippi-Chiela E; Zanin RF; Lenz G; Leal PC; Chiaradia LD; Yunes RA; Nunes RJ; Battastini AM; Morrone FB; Campos MM
Eur J Med Chem; 2012 Feb; 48():255-64. PubMed ID: 22209415
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological evaluation of beta-chloro vinyl chalcones as inhibitors of TNF-alpha and IL-6 with antimicrobial activity.
Bandgar BP; Patil SA; Korbad BL; Nile SH; Khobragade CN
Eur J Med Chem; 2010 Jun; 45(6):2629-33. PubMed ID: 20171758
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and Cytotoxic Activities of Difluoro-Dimethoxy Chalcones.
Yamali C; Gul HI; Ozgun DO; Sakagam H; Umemura N; Kazaz C; Gul M
Anticancer Agents Med Chem; 2017; 17(10):1426-1433. PubMed ID: 28356013
[TBL] [Abstract][Full Text] [Related]
34. In vitro antiproliferative and antiangiogenic effects of synthetic chalcone analogues.
Pilatova M; Varinska L; Perjesi P; Sarissky M; Mirossay L; Solar P; Ostro A; Mojzis J
Toxicol In Vitro; 2010 Aug; 24(5):1347-55. PubMed ID: 20450969
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of 2',5'-dimethoxychalcone derivatives as microtubule-targeted anticancer agents.
Tu HY; Huang AM; Hour TC; Yang SC; Pu YS; Lin CN
Bioorg Med Chem; 2010 Mar; 18(6):2089-2098. PubMed ID: 20199865
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and anti-cancer activity of chalcone linked imidazolones.
Kamal A; Ramakrishna G; Raju P; Viswanath A; Ramaiah MJ; Balakishan G; Pal-Bhadra M
Bioorg Med Chem Lett; 2010 Aug; 20(16):4865-9. PubMed ID: 20637611
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of methoxy-substituted chalcones and in vitro evaluation of their anticancer potential.
Ethiraj KR; Aranjani JM; Khan FR
Chem Biol Drug Des; 2013 Dec; 82(6):732-42. PubMed ID: 23834620
[TBL] [Abstract][Full Text] [Related]
38. Anthraquinone-chalcone hybrids: synthesis, preliminary antiproliferative evaluation and DNA-interaction studies.
Marković V; Debeljak N; Stanojković T; Kolundžija B; Sladić D; Vujčić M; Janović B; Tanić N; Perović M; Tešić V; Antić J; Joksović MD
Eur J Med Chem; 2015 Jan; 89():401-10. PubMed ID: 25462255
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological evaluation of benzo[d][1,3]dioxol-5-yl chalcones as antiproliferating agents.
Kamal A; Balakrishna M; Loka Reddy V; Riyaz S; Bagul C; Satyanarayana BM; Venkateswar Rao J
Chem Biol Drug Des; 2015 Nov; 86(5):1267-84. PubMed ID: 26032623
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and cytotoxic activity of N-((2-methyl-4(3H)-quinazolinon-6-yl)methyl)dithiocarbamates.
Cao SL; Wang Y; Zhu L; Liao J; Guo YW; Chen LL; Liu HQ; Xu X
Eur J Med Chem; 2010 Sep; 45(9):3850-7. PubMed ID: 20538385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
